EssilorLuxottica S.A. (ESLOY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Paris, France. Der aktuelle CEO ist Francesco Milleri.
ESLOY hat IPO-Datum 2008-01-30, 153,498 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $111.1B.
EssilorLuxottica S.A. is a global leader in ophthalmic products, designing, manufacturing, and distributing eyewear across six continents. The company operates through five business segments: Wholesale and Retail (luxury and sports eyewear brands), Lenses and Optical Instruments (including premium lens technologies such as Varilux, Crizal, Transitions, and Eyezen), Equipment (digital surfacing and coating machines), and Sunglasses and Readers (non-prescription eyewear under brands like Foster Grant and licensed labels). With a network of 490 prescription laboratories and edging-mounting facilities worldwide, EssilorLuxottica serves opticians, eye care professionals, and consumers through both wholesale and direct retail channels. The company was formed through the 2018 merger of Essilor International and Luxottica.
